Before these appropriate use criteria are consulted, it is assumed that:

  1. The focus of this AUC is on prevention of secondary hip or fragility fracture in patients who have had a previous frailty hip fracture and have received surgical intervention.
  2. The physician who is prescribing assessments or treatments for a patient is aware of indications and contraindications.
  3. The physician has an informed discussion with the patient about the treatment options and that the optimum treatment options may change over time for the patient.
  4. Patient values and preferences are taken into account.
  5. The patient has given adequate and informed consent.
  6. The physician would initiate any necessary assessments/treatments as soon as is reasonably possible post-operatively and ideally within 6 months.

I have read and understand the assumptions and disclaimer Return to homepage